Aptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of life-threatening conditions in which a combination of coagulation and inflammation are involved. The company’s primary pharmaceutical candidate, Apta-1, is being developed with the aim of preventing the high mortality rate caused by organ and tissue damage in patients diagnosed with a septic condition, among others. The company holds patent protection in strategic target markets and actively seeks business development opportunities with potential collaborators.
Looking for a particular Aptahem employee's phone or email?
Aptahem Questions
The Aptahem annual revenue was $9 million in 2026.
Mikael Lindstam is the CEO and co-founder of Aptahem.
2 people are employed at Aptahem.
Aptahem is based in Malmoe, Skane.
The NAICS codes for Aptahem are [54, 541713, 541, 54171, 5417].
The SIC codes for Aptahem are [87, 873].
Top Aptahem Employees
